A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD
Status:
Completed
Trial end date:
2020-03-18
Target enrollment:
Participant gender:
Summary
This study is a phase 1 study to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of multiple doses of HM15211 in obese subjects with NAFLD